Dasatinib
Anticancer Drug (Pyrimidine and Thiazole Derivative)
Blood cancer (Chronic myeloid leukaemia)
Why Partner with Pinnacle Life Science
Regulatory Compliance
Manufactured under WHO-GMP compliant processes at our US FDA approved facility in Baddi, Himachal Pradesh.
Consistent Quality
Rigorous quality control at every stage ensures reliable purity and potency across every batch produced.
Global Reach
Trusted by pharmaceutical partners and distributors across 90+ countries worldwide.
Mechanism of Action
Dasatinib is a BCR-ABL tyrosine kinase inhibitor that targets most imatinib-resistant BCR-ABL mutations (except the T315I and F317V mutants) by distinctly binding to active and inactive ABL-kinase. Kinase inhibition halts proliferation of leukemia cells. It also inhibits the SRC family (including SRC, LKC, YES, FYN); c-KIT, EPHA2 and platelet derived growth factor receptor (PDGFRβ).
Contact Us
